250 related articles for article (PubMed ID: 26603404)
21. Comparison of Dexamethasone Intravitreal Implant with Conventional Triamcinolone in Patients with Postoperative Cystoid Macular Edema.
Mylonas G; Georgopoulos M; Malamos P; Georgalas I; Koutsandrea C; Brouzas D; Sacu S; Perisanidis C; Schmidt-Erfurth U;
Curr Eye Res; 2017 Apr; 42(4):648-652. PubMed ID: 27612922
[TBL] [Abstract][Full Text] [Related]
22. Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France.
Korobelnik JF; Kodjikian L; Delcourt C; Gualino V; Leaback R; Pinchinat S; Velard ME
Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2307-2318. PubMed ID: 27286894
[TBL] [Abstract][Full Text] [Related]
23. Effect of combination therapy with bevacizumab and dexamethasone intravitreal implant in patients with retinal vein occlusion.
Singer MA; Bell DJ; Woods P; Pollard J; Boord T; Herro A; Porbandarwalla S
Retina; 2012 Jul; 32(7):1289-94. PubMed ID: 22466480
[TBL] [Abstract][Full Text] [Related]
24. Dexamethasone implant in pseudophakic and nonglaucomatous subgroup of diabetic macular edema patients: a real life experience.
Ozkaya A; Alagoz C; Alagoz N; Gunes H; Yilmaz I; Perente I; Yazici AT; Taskapili M
Eur J Ophthalmol; 2016 Jun; 26(4):351-5. PubMed ID: 26692061
[TBL] [Abstract][Full Text] [Related]
25. Intravitreal Dexamethasone Implant for the Treatment of Macular Edema in Chronic Non-infectious Uveitis.
Tsang AC; Virgili G; Abtahi M; Gottlieb CC
Ocul Immunol Inflamm; 2017 Oct; 25(5):685-692. PubMed ID: 27191685
[TBL] [Abstract][Full Text] [Related]
26. [Early efficacy of dexamethasone implant (OZURDEX
Sarda V; Fajnkuchen F; Nghiem-Buffet S; Grenet T; Chaine G; Giocanti-Auregan A
J Fr Ophtalmol; 2017 May; 40(5):408-413. PubMed ID: 28336283
[TBL] [Abstract][Full Text] [Related]
27. Intravitreal dexamethasone implant for recurrent cystoid macular edema due to Irvine-Gass syndrome: a prospective case series.
Sudhalkar A; Chhablani J; Vasavada A; Bhojwani D; Vasavada V; Vasavada S;
Eye (Lond); 2016 Dec; 30(12):1549-1557. PubMed ID: 27858937
[TBL] [Abstract][Full Text] [Related]
28. A 12-MONTH, SINGLE-MASKED, RANDOMIZED CONTROLLED STUDY OF EYES WITH PERSISTENT DIABETIC MACULAR EDEMA AFTER MULTIPLE ANTI-VEGF INJECTIONS TO ASSESS THE EFFICACY OF THE DEXAMETHASONE-DELAYED DELIVERY SYSTEM AS AN ADJUNCT TO BEVACIZUMAB COMPARED WITH CONTINUED BEVACIZUMAB MONOTHERAPY.
Maturi RK; Bleau L; Saunders J; Mubasher M; Stewart MW
Retina; 2015 Aug; 35(8):1604-14. PubMed ID: 25829346
[TBL] [Abstract][Full Text] [Related]
29. Early effects of dexamethasone implant on macular morphology and visual function in patients with macular edema secondary to retinal vein occlusion.
Veritti D; Macor S; Lanzetta P
Ophthalmologica; 2014; 232(3):144-8. PubMed ID: 25300393
[TBL] [Abstract][Full Text] [Related]
30. EFFICACY AND SAFETY OF DEXAMETHASONE INTRAVITREAL IMPLANT FOR PERSISTENT UVEITIC CYSTOID MACULAR EDEMA.
Khurana RN; Porco TC
Retina; 2015 Aug; 35(8):1640-6. PubMed ID: 25741813
[TBL] [Abstract][Full Text] [Related]
31. Spectral-domain optical coherence tomography in Irvine-Gass syndrome.
Minnella AM; Savastano MC; Zinzanella G; Mazzone G; Federici M; Gari M; Falsini B; Balestrazzi E
Retina; 2012 Mar; 32(3):581-7. PubMed ID: 21963486
[TBL] [Abstract][Full Text] [Related]
32. Spectral domain optical coherence tomography changes following intravitreal dexamethasone implant, Ozurdex® in patients with uveitic cystoid macular edema.
Bansal P; Agarwal A; Gupta V; Singh R; Gupta A
Indian J Ophthalmol; 2015 May; 63(5):416-22. PubMed ID: 26139803
[TBL] [Abstract][Full Text] [Related]
33. PROSPECTIVE RANDOMIZED SUBJECT-MASKED STUDY OF INTRAVITREAL BEVACIZUMAB MONOTHERAPY VERSUS DEXAMETHASONE IMPLANT MONOTHERAPY IN THE TREATMENT OF PERSISTENT DIABETIC MACULAR EDEMA.
Shah SU; Harless A; Bleau L; Maturi RK
Retina; 2016 Oct; 36(10):1986-96. PubMed ID: 27124881
[TBL] [Abstract][Full Text] [Related]
34. INTRAVITREAL DEXAMETHASONE IMPLANT IN PATIENTS WITH RANIBIZUMAB PERSISTENT DIABETIC MACULAR EDEMA.
Zhioua I; Semoun O; Lalloum F; Souied EH
Retina; 2015 Jul; 35(7):1429-35. PubMed ID: 26102440
[TBL] [Abstract][Full Text] [Related]
35. [Treatment of postoperative cystoid macular edema (Irvine-Gass syndrome) with dexamethasone 0.7 mg intravitreal implant].
Landré C; Zourdani A; Gastaud P; Baillif S
J Fr Ophtalmol; 2016 Jan; 39(1):5-11. PubMed ID: 26520410
[TBL] [Abstract][Full Text] [Related]
36. Pro Re Nata Dexamethasone Implant for Treatment-Naive Phakic Eyes with Diabetic Macular Edema: A Prospective Study.
Bilgic A; Sudhalkar A; Kodjikian L; Vasavada V; Vasavada S; Bhojwani D; Vasavada V; Srivastava S
Ophthalmol Retina; 2019 Nov; 3(11):929-937. PubMed ID: 31395504
[TBL] [Abstract][Full Text] [Related]
37. [A cost-effectiveness study of dexamethasone implants in macular edema].
Lozano López V; Serrano García M; Mantolán Sarmiento C; Pareja Ríos A; Losada Castillo MJ; Cordovés Dorta L; Quijada Fumero E; Virgós Aller T; Bullejos Molina M
Arch Soc Esp Oftalmol; 2015 Jan; 90(1):14-21. PubMed ID: 25443181
[TBL] [Abstract][Full Text] [Related]
38. Ozurdex for refractory macular edema secondary to diabetes, vein occlusion, uveitis and pseudophakia.
Teja S; Sawatzky L; Wiens T; Maberley D; Ma P
Can J Ophthalmol; 2019 Oct; 54(5):540-547. PubMed ID: 31564342
[TBL] [Abstract][Full Text] [Related]
39. Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant.
Yeh WS; Haller JA; Lanzetta P; Kuppermann BD; Wong TY; Mitchell P; Whitcup SM; Kowalski JW
Ophthalmology; 2012 Jun; 119(6):1190-8. PubMed ID: 22361318
[TBL] [Abstract][Full Text] [Related]
40. [Study of the effect of intravitreal dexamethasone implant in pseudophakic macular edema. Preliminary].
Ortega-Evangelio L; Diago Sempere T
Arch Soc Esp Oftalmol; 2015 Jul; 90(7):303-7. PubMed ID: 25817965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
